Please login to the form below

Not currently logged in

Sanofi exits Zynquista alliance with Lexicon

Sanofi receptionWill pay $260m to end collaboration

Mallinckrodt offloads CDMO for $250m

MallinckrodtMove follows US opioid settlement

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Roivant 2Could acquire up to 11 Roivant spinouts

Boehringer bolsters KRAS push with $720m Lupin deal

Signs of progress in the field are emerging

Vertex eyes type 1 diabetes cure with biotech acquisition

Vertex PharmaWill acquire Semma Therapeutics for $950m

'Therapeutic overcrowding' could hit big pharma returns

Jefferies analysts identify most at-risk companies

FDA clears Lilly’s Taltz for ankylosing spondylitis

TaltzNew indication boosts $1bn+ hopes for this year

Pfizer goes big on gene therapy with $500m facility spend

Pfizer logoContinues to build on its growing gene therapy business

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Detecting Alzheimer’s ahead of a cure
A focus on promising new research...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...